Standard BioTools Inc. Common Stock
LAB Real Time Price USDRecent trades of LAB by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by LAB's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Parallelized sample processing and library prep Sep. 24, 2024
-
Patent Title: Scientific instrument Aug. 06, 2024
-
Patent Title: Method and systems for microfluidic logic devices Aug. 02, 2022
Federal grants, loans, and purchases
- $152,726 2024-09-21 00:00:00 Agency: Department of Veterans Affairs
- $16,335 2024-09-12 00:00:00 Agency: Department of the Interior
- $13,797 2024-08-23 00:00:00 Agency: Department of Health and Human Services
- $34,639 2024-07-25 00:00:00 Agency: Environmental Protection Agency
- $78,394 2024-05-02 00:00:00 Agency: Environmental Protection Agency
- $14,176 2024-04-12 00:00:00 Agency: Department of Health and Human Services
- $68,541 2024-03-27 00:00:00 Agency: Department of Health and Human Services
- $13,797 2023-07-27 00:00:00 Agency: Department of Health and Human Services
- $52,980 2023-03-22 00:00:00 Agency: Department of Health and Human Services
- $22,652 2023-03-16 00:00:00 Agency: Department of Health and Human Services
- $79,240 2023-03-16 00:00:00 Agency: Department of the Interior
Estimated quarterly amount awarded from public contracts
Number of mentions of LAB in WallStreetBets Daily Discussion
Recent insights relating to LAB
Recent picks made for LAB stock on CNBC
ETFs with the largest estimated holdings in LAB
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view LAB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.